COVID-19 World Checkpoint Inhibitors for Treating Cancer Market Research Report (by Product Type, End-User/Application and Regions/Countries)

August 2020 | 88 pages | ID: CA5926671EBBEN
HeyReport

Abstracts

SUMMARY

Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

The report includes as follows:

The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Checkpoint Inhibitors for Treating Cancer , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Checkpoint Inhibitors for Treating Cancer market prospects to 2025 are included (in sales, consumption and price).

Market Segment as follows:

By Region / Countries

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc)
• Asia-Pacific (China, India, Japan, Southeast Asia etc)
• South America (Brazil, Argentina etc)
• Middle East & Africa (Saudi Arabia, South Africa etc)

By Type

• PD-1 inhibitors
• PD-L1 inhibitors
• CTLA-4 inhibitors

By End-User / Application

• Melanoma treatment
• Bladder cancer treatment
• Others

By Company

• Bristol-Myers Squibb(BMS)
• Merck
• Roche

Contents

PART 1 MARKET DEFINITION

1.1 Market Segment Overview
Figure Global Checkpoint Inhibitors for Treating Cancer Market Size (Million USD) 2017-2025
1.2 by Type
Table Global Checkpoint Inhibitors for Treating Cancer Market and Growth by Type
1.3 by End-Use / Application
Table Global Checkpoint Inhibitors for Treating Cancer Market and Growth by End-Use / Application

2 GLOBAL MARKET BY VENDORS

2.1 Market Share
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) by Vendors (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Vendors (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume (Volume) by Vendors (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume Share by Vendors (2017-2019)
2.2 Vendor Profile
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
2.3 Dynamic of Vendors

3 GLOBAL MARKET BY TYPE

3.1 Market Share
Table Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Type (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Type (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume (Volume) by Type (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume Share by Type (2017-2019)
3.2 Introduction of End-Use by Different Products

4 GLOBAL MARKET BY END-USE / APPLICATION

4.1 Market Share
Table Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by End-Use / Application (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume Share by End-Use / Application (2017-2019)
4.2 Overview of Consumption Characteristics
  4.2.1 Preference Driven
  4.2.2 Substitutability
  4.2.3 Influence by Strategy
  4.2.4 Professional Needs

5 GLOBAL MARKET BY REGIONS

5.1 Market Share
Table Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Regions (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Regions (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume (Volume) by Regions (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume Share by Regions (2017-2019)
5.2 Regional Market Growth
  5.2.1 North America
Figure North America Market Growth 2015-2018
  5.2.2 Europe
Figure Europe Market Growth 2017-2019
  5.2.3 Asia-Pacific
Figure Asia-Pacific Market Growth 2017-2019
  5.2.4 South America
Figure South America Market Growth 2017-2019
  5.2.5 Middle East & Africa
Figure Middle East & Africa Market Growth 2017-2019

6 NORTH AMERICA MARKET

6.1 by Type
Table North America Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Type (2017-2019)
Table North America Checkpoint Inhibitors for Treating Cancer Market Share by Type (2017-2019)
6.2 by End-Use / Application
Table North America Checkpoint Inhibitors for Treating Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table North America Checkpoint Inhibitors for Treating Cancer Market Share by End-Use / Application (2017-2019)
6.3 by Regions
Table North America Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Regions (2017-2019)
Table North America Checkpoint Inhibitors for Treating Cancer Market Share by Regions (2017-2019)

7 EUROPE MARKET

7.1 by Type
Table Europe Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Type (2017-2019)
Table Europe Checkpoint Inhibitors for Treating Cancer Market Share by Type (2017-2019)
7.2 by End-Use / Application
Table Europe Checkpoint Inhibitors for Treating Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Checkpoint Inhibitors for Treating Cancer Market Share by End-Use / Application (2017-2019)
7.3 by Regions
Table Europe Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Regions (2017-2019)
Table Europe Checkpoint Inhibitors for Treating Cancer Market Share by Regions (2017-2019)

8 ASIA-PACIFIC MARKET

8.1 by Type
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Share by Type (2017-2019)
8.2 by End-Use / Application
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Share by End-Use / Application (2017-2019)
8.3 by Regions
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Share by Regions (2017-2019)

9 SOUTH AMERICA MARKET

9.1 by Type
Table South America Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Type (2017-2019)
Table South America Checkpoint Inhibitors for Treating Cancer Market Share by Type (2017-2019)
9.2 by End-Use / Application
Table South America Checkpoint Inhibitors for Treating Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table South America Checkpoint Inhibitors for Treating Cancer Market Share by End-Use / Application (2017-2019)
9.3 by Regions
Table South America Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Share by Regions (2017-2019)

10 MIDDLE EAST & AFRICA MARKET

10.1 by Type
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Share by Type (2017-2019)
10.2 by End-Use / Application
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Share by End-Use / Application (2017-2019)
10.3 by Regions
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Share by Regions (2017-2019)

11 MARKET FORECAST

11.1 Global Market Forecast (2020-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Volume (Volume) and Growth Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) Forecast by Regions (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share Forecast by Regions (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume Share Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) Forecast by Type (2020-2025)
Table Global Checkpoint Inhibitors for Treating CancerMarket Share by Forecast Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share Forecast by End-Use / Application (2020-2025)

12 KEY MANUFACTURERS


12.BRASKEM BRISTOL-MYERS SQUIBB(BMS)

  12.1.2 Company Overview
  12.1.2 Product and End-User / Application
  12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb(BMS)
12.2 Merck
12.3 Roche

13 OVERVIEW OF INDUSTRY DEVELOPMENT (COVID-19)

13.1 Analysis of Industry Development (COVID-19)
13.2 Industry Development Stage (COVID-19)
13.3 General Situation of Industry Development (COVID-19)
13.4 Analysis of Industry Development Characteristics (COVID-19)

14 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Checkpoint Inhibitors for Treating Cancer Market and Growth by Type
Table Global Checkpoint Inhibitors for Treating Cancer Market and Growth by End-Use / Application
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) by Vendors (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Vendors (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume (Volume) by Vendors (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Type (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Type (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume (Volume) by Type (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume Share by Type (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by End-Use / Application (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume Share by End-Use / Application (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Regions (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Regions (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume (Volume) by Regions (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume Share by Regions (2017-2019)
Table North America Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Type (2017-2019)
Table North America Checkpoint Inhibitors for Treating Cancer Market Share by Type (2017-2019)
Table North America Checkpoint Inhibitors for Treating Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table North America Checkpoint Inhibitors for Treating Cancer Market Share by End-Use / Application (2017-2019)
Table North America Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Regions (2017-2019)
Table North America Checkpoint Inhibitors for Treating Cancer Market Share by Regions (2017-2019)
Table Europe Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Type (2017-2019)
Table Europe Checkpoint Inhibitors for Treating Cancer Market Share by Type (2017-2019)
Table Europe Checkpoint Inhibitors for Treating Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Checkpoint Inhibitors for Treating Cancer Market Share by End-Use / Application (2017-2019)
Table Europe Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Regions (2017-2019)
Table Europe Checkpoint Inhibitors for Treating Cancer Market Share by Regions (2017-2019)
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Share by Type (2017-2019)
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Share by Regions (2017-2019)
Table South America Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Type (2017-2019)
Table South America Checkpoint Inhibitors for Treating Cancer Market Share by Type (2017-2019)
Table South America Checkpoint Inhibitors for Treating Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table South America Checkpoint Inhibitors for Treating Cancer Market Share by End-Use / Application (2017-2019)
Table South America Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Share by Regions (2017-2019)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Share by Type (2017-2019)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Share by Regions (2017-2019)
Table Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) Forecast by Regions (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share Forecast by Regions (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market Volume Share Forecast by Regions (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) Forecast by Type (2020-2025)
Table Global Checkpoint Inhibitors for Treating CancerMarket Share by Forecast Type (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb(BMS)
Table Sales Revenue, Volume, Price, Cost and Margin of Merck
Table Sales Revenue, Volume, Price, Cost and Margin of Roche

List Of Figures

LIST OF FIGURES

Figure Global Checkpoint Inhibitors for Treating Cancer Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Checkpoint Inhibitors for Treating Cancer Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Volume (Volume) and Growth Forecast (2020-2025)